Ipratropium Bromide/Salbutamol Neutec

Ipratropium Bromide, the active ingredient in Ipratropium Bromide/Salbutamol Neutec, is a bronchodilator (Anticholinergic + Short‑acting β2‑agonist) presented as a combination inhalation product for inhalation use. It treats chronic obstructive pulmonary disease (COPD) and asthma in patients requiring rapid bronchodilation.

GNH USA supplies Ipratropium Bromide/Salbutamol Neutec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. It is manufactured to EU standards and distributed globally.

Ipratropium Bromide/Salbutamol is a bronchodilator indicated for respiratory conditions that involve airway narrowing.

- Chronic obstructive pulmonary disease (COPD): improves airflow and reduces breathlessness. - Asthma: provides rapid relief of bronchoconstriction and improves symptom control. - Bronchospasm: alleviates acute airway narrowing in various respiratory conditions.

The following adverse reactions have been reported with the combination inhalation product.

Common Side Effects: - Dry mouth: reduced salivary secretion. - Cough or throat irritation: local irritation from inhaled particles. - Headache: mild to moderate intensity. - Tremor: fine muscle shaking, especially of the hands. - Palpitations: sensation of rapid or irregular heartbeat. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening airway obstruction after inhalation. - Angioedema: swelling of the face, lips, or tongue. - Tachyarrhythmia: rapid or irregular heart rhythm. - Severe allergic reaction (anaphylaxis): systemic hypersensitivity. - Hyperglycaemia: elevated blood glucose, particularly in diabetic patients.

Before prescribing or using this inhalation product, consider the following precautions.

- Assess renal function: ipratropium is renally excreted; dose adjustment may be needed in severe impairment. - Monitor cardiovascular status: salbutamol may cause tachycardia or palpitations. - Avoid use in patients with known hypersensitivity to either component. - Use with caution in patients with narrow‑angle glaucoma. - Do not exceed prescribed frequency: overuse increases risk of systemic side effects. - Store below 25°C: keep in original container, protect from moisture and heat.

Potential drug interactions should be reviewed prior to initiating therapy.

Major Interactions (Avoid): - Beta‑blockers: may antagonize bronchodilator effect. - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension. - Tricyclic antidepressants: additive cardiovascular stimulation. - Diuretics: may exacerbate hypokalaemia. - Other anticholinergics: additive anticholinergic burden.

Moderate Interactions (Monitor Closely):\n- Theophylline: additive bronchodilation; monitor serum levels. - Corticosteroids: increased risk of oral thrush with inhaled use. - Diabetes medications: salbutamol can raise blood glucose levels. - Antihistamines: may increase dry‑mouth sensation. - Ritonavir: may increase salbutamol plasma concentrations.